AXIM BIOTECHNOLOGIES, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-4.8M | $-4.8M | — | $911.3K |
| FY2019 | $-5.0M | $-5.0M | — | $1.8M |
| FY2020 | $-3.2M | $-3.3M | $97.3K | $2.3M |
| FY2021 | $-2.5M | $-2.5M | $40.5K | $1.1M |
| FY2022 | $-2.0M | $-2.1M | $8.7K | $1.1M |